P2.081 Central mechanism of visual feedback for motor dysfumction in Parkinson's disease—near infra-red spectroscopic (NIRS) topographic study

2008 ◽  
Vol 14 ◽  
pp. S64
Author(s):  
Y. Matsuo ◽  
N. Kamata ◽  
K. Abe
Motor Control ◽  
1998 ◽  
Vol 2 (3) ◽  
pp. 251-277 ◽  
Author(s):  
Howard Poizner ◽  
Olga I. Fookson ◽  
Michail B. Berkinblit ◽  
Wayne Hening ◽  
Gregory Feldman ◽  
...  

A three-dimensional tracking system was used to examine whether subjects with Parkinson's disease (PD) would show characteristic performance deficits in an unconstrained pointing task. Five targets were presented in a pyramidal array in space to 11 individuals with mild to moderate PD and 8 age-matched controls. After the target was indicated, subjects closed their eyes and pointed to the remembered target locations without vision. Despite the absence of visual feedback during movement, PD subjects were as accurate overall as controls. However, PD subjects showed greater variable errors, more irregular trajectories, and a vertical endpoint bias in which their endpoints were significantly lower than controls. They also showed deficiencies in the compensatory organization of joint rotations to ensure consistency in azimuthal (horizontal) positioning of the arm endpoint. We concluded that, under appropriate task conditions, PD subjects may not show overall deficits in accuracy even when making targeted movements at normal speed without visual feedback. Nevertheless, our findings indicate that there are certain dimensions of performance which are selectively altered in Parkinson's disease even when overall performance is normal.


2017 ◽  
Vol 60 (6S) ◽  
pp. 1818-1825 ◽  
Author(s):  
Yana Yunusova ◽  
Elaine Kearney ◽  
Madhura Kulkarni ◽  
Brandon Haworth ◽  
Melanie Baljko ◽  
...  

Purpose The purpose of this pilot study was to demonstrate the effect of augmented visual feedback on acquisition and short-term retention of a relatively simple instruction to increase movement amplitude during speaking tasks in patients with dysarthria due to Parkinson's disease (PD). Method Nine patients diagnosed with PD, hypokinetic dysarthria, and impaired speech intelligibility participated in a training program aimed at increasing the size of their articulatory (tongue) movements during sentences. Two sessions were conducted: a baseline and training session, followed by a retention session 48 hr later. At baseline, sentences were produced at normal, loud, and clear speaking conditions. Game-based visual feedback regarding the size of the articulatory working space (AWS) was presented during training. Results Eight of nine participants benefited from training, increasing their sentence AWS to a greater degree following feedback as compared with the baseline loud and clear conditions. The majority of participants were able to demonstrate the learned skill at the retention session. Conclusions This study demonstrated the feasibility of augmented visual feedback via articulatory kinematics for training movement enlargement in patients with hypokinesia due to PD. Supplemental Materials https://doi.org/10.23641/asha.5116840


1990 ◽  
Vol 110 (2) ◽  
pp. 228-235 ◽  
Author(s):  
A. Beuter ◽  
J.G. Milton ◽  
C. Labrie ◽  
L. Glass ◽  
S. Gauthier

2011 ◽  
Vol 211 (2) ◽  
pp. 277-286 ◽  
Author(s):  
S. Levy-Tzedek ◽  
H. I. Krebs ◽  
J. E. Arle ◽  
J. L. Shils ◽  
H. Poizner

1999 ◽  
Vol 129 (3) ◽  
pp. 0477-0481 ◽  
Author(s):  
X. Liu ◽  
S. A. Tubbesing ◽  
T. Z. Aziz ◽  
R. C. Miall ◽  
J. F. Stein

2020 ◽  
Vol 34 (10) ◽  
pp. 891-903
Author(s):  
Shu-Han Yu ◽  
Ruey-Meei Wu ◽  
Cheng-Ya Huang

Background Restricted attentional resource and central processing in patients with Parkinson’s disease (PD) may reduce the benefit of visual feedback in a dual task. Objectives Using brain event-related potentials (ERPs), this study aims to investigate the neural mechanisms of posture visual feedback and supraposture visual feedback during performing of a posture-motor dual task. Methods Eighteen patients with PD and 18 healthy controls stood on a mobile platform (postural task) and executed a manual force-matching task (suprapostural task) concurrently with provided visual feedback of platform movement (posture-feedback condition) or force output (force-feedback condition). The platform movement, force-matching performance, and ERPs (P1, N1, and P2 waves) were recorded. Results Both PD and control groups had superior force accuracy in the force-feedback condition. Decreased postural sway by posture-feedback was observed in healthy controls but not in PD. Force-feedback led to a greater frontal area N1 peak in PD group but smaller N1 peaks in control group. In addition, force-feedback led to smaller P2 peaks of the frontal and sensorimotor areas among PD patients but greater P2 peaks of the sensorimotor and parietal-occipital areas among healthy controls. However, P1 modulations was present only in healthy controls. Conclusions Force-feedback had positive effect on force accuracy in both PD and healthy individuals; however, the beneficial effect of posture-feedback on posture balance is not observed in PD. These findings are the first to suggest that PD could recruit more attentional resources in dual-task preparation to enhance suprapostural accuracy and avoid degrading postural stability by supraposture visual feedback.


BMC Neurology ◽  
2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Maarten RC van den Heuvel ◽  
Erwin EH van Wegen ◽  
Cees JT de Goede ◽  
Ingrid AL Burgers-Bots ◽  
Peter J Beek ◽  
...  

2018 ◽  
Vol 46 (4) ◽  
pp. 891-909 ◽  
Author(s):  
Ruby Macdonald ◽  
Katy Barnes ◽  
Christopher Hastings ◽  
Heather Mortiboys

Mitochondrial abnormalities have been identified as a central mechanism in multiple neurodegenerative diseases and, therefore, the mitochondria have been explored as a therapeutic target. This review will focus on the evidence for mitochondrial abnormalities in the two most common neurodegenerative diseases, Parkinson's disease and Alzheimer's disease. In addition, we discuss the main strategies which have been explored in these diseases to target the mitochondria for therapeutic purposes, focusing on mitochondrially targeted antioxidants, peptides, modulators of mitochondrial dynamics and phenotypic screening outcomes.


Sign in / Sign up

Export Citation Format

Share Document